Pathogen News and Research

RSS

Researchers investigate cellular factors that could be significant for COVID-19 infection

An infection with the coronavirus SARS-CoV-2 can affect multiple organs. With this in mind, researchers of the German Center for Neurodegenerative Diseases (DZNE) and Cornell University in the US have investigated cellular factors that could be significant for an infection.

4 Sep 2020

Researchers discover the developmental process of strong immune T-cells

There are memory cells that remember previously encountered pathogens and help to react quickly and strongly when exposed to them again.

4 Sep 2020

Researchers discover the developmental process of novel immune T cells

Memory cells essentially recall formerly encountered pathogens and help respond strongly and rapidly when they are exposed to this foreign matter again.

3 Sep 2020

Study reveals gene that provides resistance to tomatoes from bacterial speck disease

Bacterial speck disease, which reduces both fruit yield and quality, has been a growing problem in tomatoes over the last five years.

3 Sep 2020

Gut bacterium is linked to increased risk of stomach cancer

The bacterium Helicobacter pylori is linked to increased risk of stomach cancer, and is genetically highly variable. A new study by researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich explores the role played by this diversity in the early phase of infection in adult humans.

3 Sep 2020

Researchers identify protein that causes adverse side effects in gastric cancer patients

Gastric cancer is one of the major causes of cancer-related mortality around the world. It is known for its potential to spread across the peritoneal cavity.

1 Sep 2020

Study explores additional factors that influence poultry food safety

Current poultry food safety guidelines for Salmonella, the leading cause of foodborne illness outbreaks, are inadequate.

27 Aug 2020

Researchers discover antibodies that may provide effective immunity against SARS-CoV-2

A new study by researchers at MassBiologics of UMass Medical School published in Nature Communications suggests that COVID specific IgA monoclonal antibodies may provide effective immunity in the respiratory system against the novel coronavirus - a potentially critical feature of an effective vaccine.

25 Aug 2020

New study shows promise for developing COVID-19 vaccine

When news about a novel coronavirus switched from a chronicle of its progress in China to headlines about a worldwide COVID-19 pandemic, Gladstone Institutes scientist Nadia Roan, PhD, was in the midst of publishing several papers on T cells and their role in HIV spread and long-lasting infections.

24 Aug 2020

Cytokine storms in COVID-19 patients may prevent the development of long-term immunity

Shiv Pillai, MD, Ph.D., investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical School (HMS), recently published a paper in Cell showing that that high levels of some cytokines seen in COVID-19 patients, as part of a cytokine storm, may prevent the development of long-term immunity to SARS-CoV-2, the virus that causes COVID-19.

20 Aug 2020

Study reveals a mechanism for lower-quality immune response in patients with severe COVID-19

The release of massive amounts of proteins called cytokines can lead to some of the most severe symptoms of COVID-19.

From Harvard Medical School 20 Aug 2020

Greater gut microbial diversity in kidney cancer patients linked to better treatment outcomes

Physicians at City of Hope, working in collaboration with scientists at Translational Genomics Research Institute (TGen), have found that greater gut microbial diversity in patients with metastatic kidney cancer is associated with better treatment outcomes on Food and Drug Administration-approved immunotherapy regimens.

20 Aug 2020

Novel molecular survival strategy of Shigella bacterium uncovered

Enteric pathogens, such as the bacterium Shigella, can cause severe intestinal disease with bloody diarrhea. In a new study, researchers from Tokyo Medical and Dental University (TMDU) discovered a novel molecular survival strategy by which Shigella is able to cause damage to the intestines despite two elaborate protective mechanisms used by host cells.

19 Aug 2020

Researchers discover the exit route for Vibrio bacteria from cells

As soon as the foodborne pathogen Vibrio parahaemolyticus infects a human intestinal cell, the bacteria are already planning their escape. After all, once it is in and multiplies, the bacterium must find a way out to infect new cells.

19 Aug 2020

Study shows how proteins act as a defense mechanism to protect their own DNA

Viruses usually inject their DNA into a host cell to multiply. As soon as this foreign material penetrates the intracellular fluid, it activates a defense mechanism called the cGAS-STING pathway.

18 Aug 2020

New method reverses antibiotic resistance in certain bacteria

Scientists have identified a novel method in which hydrogen sulfide (H2S) is used to reverse antibiotic resistance in certain bacteria.

13 Aug 2020

UC Riverside physicist receives NIH grant to study how pathogens evolve

For several years, physicist John Barton at the University of California, Riverside, has been working on developing models to understand and predict how pathogens, such as HIV, evolve. This research pursuit has just received support from the National Institutes of Health.

11 Aug 2020

Researchers identify new mechanism of papillomavirus that tricks the human immune system

Certain antibodies are known to protect humans from viral infections—or perhaps not?

6 Aug 2020

New UK supply contract for COVID-19 sample collection kits

EKF Diagnostics Holdings plc, the AIM listed point-of-care business, announces that it has received an initial order worth £3 m from a partner from the private sector to supply PrimeStore MTM, a novel patented sample collection device, to be used in a COVID-19 testing programme for UK staff.

From EKF Diagnostics 5 Aug 2020

A New Way of Killing Tuberculosis

AZoLifeSciences speaks to Dr. Tim Blower about his research into tuberculosis, and how the discovery of a new toxin could lead to new anti-TB drugs.

From Durham University 5 Aug 2020

Pathogen News and Research

Researchers investigate cellular factors that could be significant for COVID-19 infection

Researchers discover the developmental process of strong immune T-cells

Researchers discover the developmental process of novel immune T cells

Study reveals gene that provides resistance to tomatoes from bacterial speck disease

Gut bacterium is linked to increased risk of stomach cancer

Researchers identify protein that causes adverse side effects in gastric cancer patients

Study explores additional factors that influence poultry food safety

Researchers discover antibodies that may provide effective immunity against SARS-CoV-2

New study shows promise for developing COVID-19 vaccine

Cytokine storms in COVID-19 patients may prevent the development of long-term immunity

Study reveals a mechanism for lower-quality immune response in patients with severe COVID-19

Greater gut microbial diversity in kidney cancer patients linked to better treatment outcomes

Novel molecular survival strategy of Shigella bacterium uncovered

Researchers discover the exit route for Vibrio bacteria from cells

Study shows how proteins act as a defense mechanism to protect their own DNA

New method reverses antibiotic resistance in certain bacteria

UC Riverside physicist receives NIH grant to study how pathogens evolve

Researchers identify new mechanism of papillomavirus that tricks the human immune system

New UK supply contract for COVID-19 sample collection kits

A New Way of Killing Tuberculosis

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics